Bait and Switch -The FDA & Big Pharma's Move Against GLP1 Access

This Is Not Covered — Dr. Ashley Froese — Bait and Switch -The FDA & Big Pharma's Move Against GLP1 Access

Channel: This Is Not Covered - Dr. Ashley Froese · Our label: Clinician educator · Source: youtube.com/watch?v=RBqjxTHOTj0

What this video covers

Well, they made a proposal to get 503barmacies to stop being allowed to mass-roduce these drugs. And most people who have heard about this seem confused because the headlines aren’t telling the whole story. They’re really just scaring people or click baiting you. So, let me tell you what happened and why it matters.

Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.

Key points, in the speaker’s own framing

• But in all seriousness, there’s a bit of confusion here on what’s actually going on because even thoughies aren’t allowed to make GLP-1 drugs in bulk anymore, not all compoundingies would be banned from dispensing them to people.
• Well, these are generally smaller compoundingies that fill prescriptions for individuals based on a prescribers’s instructions.
• So the FDA just proposed removing semileutide, tzepide and laglutide, all GLP-1 drugs from the 503b bulks list, the larger facility.
• The FDA’s stated reason for doing this is patient safety and returning to gold standard manufacturing, but they just removed the drug from the facilities that are meeting the higher federal standards.
• The FDA’s legal justification is that there is no longer a clinical need for compounded versions of these drugs because the branded drugs are now available.
• To access a compounded version through a 503A pharmacy, patients increasingly need a physician or prescriber to document specific clinical reason why the brand name won’t work.

Read next

• GLP-1 class — more videos
• Semaglutide — more videos
• Tirzepatide — more videos
• All videos from this channel

Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.